HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/6/F1315    most recent 00450.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Stricklett, P. K. Articles by Kohan, D. E. Search for Related Content PubMed PubMed Citation Articles by Stricklett, P. K. Articles by Kohan, D. E.

CALL FOR PAPERS
Endothelins

Endothelin-1 stimulates NO production and inhibits cAMP accumulation in rat inner medullary collecting duct through independent pathways

Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, Utah

Submitted 11 November 2005 ; accepted in final form 23 December 2005

Endothelin-1 (ET-1) inhibition of vasopressin (AVP)-stimulated cAMP accumulation in the collecting duct has been hypothesized to be mediated, at least in part, by nitric oxide (NO). To examine this, the effect of ET-1 on NO production by acutely isolated rat inner medullary collecting duct (IMCD) cell suspensions and the role of NO in mediating ET-1 effects on AVP-stimulated cAMP accumulation were studied. ET-1 dose dependently (first evident at 100 pM ET-1) increased IMCD NO production as determined by DAF-FM fluorescence. ET_B receptor (BQ-788), but not ET_A receptor (BQ-123), antagonism blocked this effect. Nonspecific NO synthase (NOS) inhibitors [N^G-nitro-L-arginine methyl ester (L-NAME) or N^G-monomethyl-L-arginine] or NOS-1 inhibitors (SMTC or VNIO) inhibited the ET-1 response, whereas NOS-2 or NOS-3 inhibitors (L-NAA or 1400W) were ineffective. ET-1 also increased cGMP accumulation. ET-1 caused a 35% reduction in AVP-stimulated cAMP levels; however, this response was not affected by L-NAME or SMTC. The addition of L-arginine, NADPH, tetrahydrobiopterin, or tempol (to reduce superoxide-dependent conversion of NO to peroxynitrate) did not affect the response. NO donors (SNAP or spermine NONOate), at concentrations that stimulated DAF-FM fluorescence and increased cGMP levels, did not alter AVP-stimulated cAMP accumulation in the IMCD cell suspensions. In conclusion, ET-1 stimulates IMCD NO production through activation of the ET_B receptor and NOS-1. However, neither ET-1-mediated NO production nor NO donors inhibit AVP-stimulated cAMP accumulation, indicating that NO does not mediate ET-1 inhibition of cAMP production by the IMCD.

nitric oxide synthase; cyclic guanosine 5'-monophosphate; endothelin B receptor

This article has been cited by other articles:

				D. L. Kellogg Jr., J. L. Zhao, and Y. Wu Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H123 - H129. [Abstract] [Full Text] [PDF]

				D. Nakano, J. S. Pollock, and D. M. Pollock Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1205 - F1211. [Abstract] [Full Text] [PDF]

				R. A. Fenton and M. A. Knepper Mouse Models and the Urinary Concentrating Mechanism in the New Millennium Physiol Rev, October 1, 2007; 87(4): 1083 - 1112. [Abstract] [Full Text] [PDF]

				Y. Ge, A. Bagnall, P. K. Stricklett, K. Strait, D. J. Webb, Y. Kotelevtsev, and D. E. Kohan Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1274 - F1280. [Abstract] [Full Text] [PDF]